Amiodarone: An emergency medicine perspective

Emergency Medicine

Volumn 14, Issue 4, 2002, Pages 422-429

  Taylor, Simone E ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Adverse effects; Amiodarone; Atrial fibrillation; Ventricular arrhythmias

Indexed keywords

AMIODARONE; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CIMETIDINE; CORTICOSTEROID; CYCLOSPORIN; DEETHYLAMIODARONE; DIGOXIN; DILTIAZEM; FLECAINIDE; LIDOCAINE; PHENYTOIN; PROPYLTHIOURACIL; QUINIDINE; RIFAMPICIN; SOTALOL; THEOPHYLLINE; THYROXINE; VERAPAMIL; WARFARIN;

ANOREXIA; ATAXIA; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CLINICAL TRIAL; CONSTIPATION; CORNEA DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; EMERGENCY MEDICINE; EPIDIDYMITIS; ERECTILE DYSFUNCTION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HEPATITIS; HUMAN; HYPERTHYROIDISM; HYPOTENSION; HYPOTHYROIDISM; INTERSTITIAL PNEUMONIA; LIVER CIRRHOSIS; LUNG FIBROSIS; LUNG TOXICITY; MEMORY DISORDER; NAUSEA; OPTIC NERVE DISEASE; PARESTHESIA; PHOTODERMATOSIS; PHOTOPHOBIA; PHOTOSENSITIVITY DISORDER; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; THYROTOXICOSIS; TREMOR; VISUAL IMPAIRMENT;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DRUG INTERACTIONS; HUMANS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0036911684     PISSN: 10356851     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2026.2002.00383.x     Document Type: Review

References (26)

1. Hardman JG, Limbird LE, Goodman Gilman A, eds. The Pharmacological Basis of Therapeutics, 10th Edn. New York: McGraw-Hill, 2001.
2. Pollak PT. Oral amiodarone: Historical overview and development. Pharmacotherapy 1998; 18: 121S-6S.
3. Naccarelli GV, Jalal S. Intravenous amiodarone: Another option in the acute management of sustained ventricular tachyarrhythmias. Circulation 1995; 92: 3154-5.
4. Kodama I, Kamiya K, Toyama J. Amiodarone: Ionic and cellular mechanisms of action of the most promising class III agent. Am. J. Cardiol. 1999; 84: 20R-8R.
5. Sanofi Synthelabo. Cordarone® (amiodarone) Product Monograph. Lane Cove, Australia: 2000.
6. Singh BN. Amiodarone: The expanding antiarrhythmic role and how to follow a patient on chronic therapy. Clin. Cardiol. 1997; 20: 608-18.
7. Goldschlager N, Epstein AE, Naccarelli G et al. Practical guidelines for clinicians who treat patients with amiodarone. Arch. Intern. Med. 2000; 160: 1741-8.
8. Atkins DL, Dorian P, Gonzalez ER et al. Treatment Tachyarrhythmias. Ann. Emerg. Med. 2001; 37: S91-S109.
9. Anonymous. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6, Section 7: Algorithm approach to ACLS Emergencies. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102 (Suppl. 1): I 136-65.
10. Scheinman MM, Levine JH, Cannom DS et al. Dose ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 1995; 92: 3264-72.
11. Clemo HF, Wood MA, Gilligan DM, Ellenbogen KA. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am. J. Cardiol. 1998; 81: 594-8.
12. Vardas PE, Kochiadakas GE, Igoumenidis NE, Tsatsakis AM, Simantirakis EN, Chlouverakis GI. Amiodarone as a first choice drug for restoring sinus rhythm in patients with atrial fibrillation: A randomised, controlled study. Chest 2000; 117: 1538-45.
13. Joseph AP, Ward MR. A prospective, randomised, controlled trial comparing the efficacy and safety of sotalol, amiodarone and digoxin for the reversion of new onset atrial fibrillation. Ann. Emerg. Med. 2000; 36: 1-9.
14. Kochiadakas GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: A comparative, placebo controlled study. Heart 2000; 84: 251-7.
15. Anonymous. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6 Section 5. Pharmacology I. Agents for arrhythmias. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102: I 112-28.
16. Anonymous. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6, Section 1: Introduction to ACLS 2000 The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102: I 1-11.
17. Kudenchuk PJ, Cobb LA, Copass MK et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N. Eng. J. Med. 1999; 341: 871-8.
18. Dorian P, Cass D, Schwartz Cooper B, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N. Engl. J. Med. 2002; 346: 884-90.
19. Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival trial of antiarrhythmic treatment in congestive heart failure (CHF-STAT). N. Engl. J. Med. 1995; 333: 77-82.
20. Dusman RE, Stanton MS, Miles WM et al. Clinical features of amiodarone induced pulmonary toxicity. Circulation 1990; 82: 51-9.
21. Hilleman D, Miller MA, Parker R, Doering P, Pieper JA. Optimal management of amiodarone therapy: Efficacy and side effects. Pharmacotherapy 1998; 18: 138S-45S.
22. Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001; 120: 275-82.
23. Newman CM, Price A, Davies DW, Gray TA, Weetman AP. Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998; 79: 121-7.
24. Rogers KC, Wolfe DA. Amiodarone induced blue-gray syndrome. Ann. Pharmacother. 2000; 34: 1075.
25. Hansten PD, Horn JR. Drug Interactions Analysis and Management. St Louis: Wolters Kluwer Co, 1999.
26. Stockley IH. Drug Interactions, 5th Edn. London: The Pharmaceutical Press, 1999.